Birth outcomes after prenatal exposure to antiepileptic drugs - A population-based study

Epilepsia

Volumn 55, Issue 11, 2014, Pages 1714-1721

  Kilic, Demet ^a   Pedersen, Henrik ^b   Kjaersgaard, Maiken Ina Siegismund ^b   Parner, Erik Thorlund ^b   Vestergaard, Mogens ^b   Sørensen, Merete Juul ^a   Olsen, Jørn ^b   Bech, Bodil Hammer ^b   Christensen, Jakob ^a   Pedersen, Lars Henning ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Antiepileptic drugs; Birth weight; Gestational age; Head circumference; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CHILD; COHABITATION; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG USE; EDUCATIONAL STATUS; EPILEPSY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INCOME; LOW BIRTH WEIGHT; LOW DRUG DOSE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SMOKING; MONOTHERAPY; POLYPHARMACY; POPULATION RESEARCH; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; PROGENY; REIMBURSEMENT; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; SUBSTANCE ABUSE; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; RISK; YOUNG ADULT;

ADULT; ANTICONVULSANTS; CHILD; COHORT STUDIES; EPILEPSY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RISK; YOUNG ADULT;

EID: 84921993742     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12758     Document Type: Article

References (23)

1. World Health Organization. Epilepsy. 2012. Available at: http://www.who.int/mediacentre/factsheets/fs999/en/ (accessed August 14, 2014).
2. Kjaer D, Christensen J, Bech BH, et al. Preschool behavioral problems in children prenatally exposed to antiepileptic drugs - a follow-up study. Epilepsy Behav 2013;29:407-411.
3. Christensen J, Gronborg TK, Sorensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696-1703.
4. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12(3):244-252.
5. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133-141.
6. Harden CL, Meador KJ, Pennell PB, et al. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009;50:1237-1246.
7. Meador K, Reynolds MW, Crean S, et al. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008;81:1-13.
8. Hvas CL, Henriksen TB, Ostergaard JR. Birth weight in offspring of women with epilepsy. Epidemiol Rev 2000;22:275-282.
9. Artama M, Gissler M, Malm H, et al. Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-369.
10. Veiby G, Daltveit AK, Engelsen BA, et al. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol 2014;261:579-588.
11. Almgren M, Kallen B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero-influence on head circumference in newborns. Seizure 2009;18:672-675.
12. WHO ATC code. 2014. Available at: http://www.whocc.no/ (accessed August 14, 2014).
13. Efron B, Tibshirani R. Bootstrap methods for standard errors, conficence intervals, and other measures of statistical accuracy. Stat Sci 1986;1:54-75.
14. Veiby G, Daltveit AK, Engelsen BA, et al. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia 2009;50:2130-2139.
15. Pennell PB, Klein AM, Browning N, et al. Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 2012;24:449-456.
16. Hernandez-Diaz S, Mittendorf R, Smith CR, et al. Association between topiramate and zonisamide use during pregnancy and low birth weight. Obstet Gynecol 2014;123:21-28.
17. Olesen C, Sondergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology 2001;12:497-501.
18. Christensen J, Vestergaard M, Olsen J, et al. Validation of epilepsy diagnoses in the Danish National Hospital Register. Epilepsy Res 2007;75:162-170.
19. Yerby MS. Special considerations for women with epilepsy. Pharmacotherapy 2000;20:159S-170S.
20. Kristensen J, Langhoff-Roos J, Skovgaard LT, et al. Validation of the Danish Birth Registration. J Clin Epidemiol 1996;49:893-897.
21. Crane JM, Keough M, Murphy P, et al. Effects of environmental tobacco smoke on perinatal outcomes: a retrospective cohort study. BJOG 2011;118:865-871.
22. Leonardi-Bee J, Smyth A, Britton J, et al. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008;93:F351-F361.
23. Hvas CL, Henriksen TB, Ostergaard JR, et al. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000;107:896-902.